Becton, Dickinson and Company
Head Quarters
1 Becton Drive USWebsite
http://www.bd.comIndustry
MedicalSpecialtiesEmployees
50928Exchange
New York Stock Exchange, Inc.Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also pro
Key statistics
Margins | Stock |
---|---|
Revenue per Employee | $0.00 |
Current Ratio | 1 |
Gross Margin (%) | 0.49% |
Net Margin (%) | 0.03% |
Returns | Stock |
Sales | $12.32B |
Sales Growth (% qtr vs. yr ago) | 0.00% |
Net Income | $723.00M |
NI Growth (% qtr vs. yr ago) | 0.00% |
Price/Sales | 16.64 |
EPS | $6.00 |